HomeOwner SearchCategory Search
Visit USCOCombinational immunotherapy of anti-OX40 antibody and IDO inhibitor synergistically enhances anti-tumor immune T cell-mediated response
Text Registration
Copyright Title
Combinational immunotherapy of anti-OX40 antibody and IDO inhibitor synergistically enhances anti-tumor immune T cell-mediated response
Status
Published
on 27 Sept 2016
Year of Creation
2016
Copyright Claimant
Zuzana Jirina Berrong
Registration Number
TX0008273801
on 27 Sept 2016Copyright Summary
The U.S. Copyright record (Registration Number: TX0008273801) dated 27 Sept 2016, pertains to an electronic file (eService) titled "Combinational immunotherapy of anti-OX40 antibody and IDO inhibitor synergistically enhances anti-tumor immune T cell-mediated response" created in 2016. The copyright holder is Zuzana Jirina Berrong, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Zuzana Jirina Berrong.
Application Details
Registration Number
TX0008273801
Registration Date
9/27/2016
Year of Creation
2016
Agency Marc Code
DLC-CO
Record Status
New
Physical Description
Electronic file (eService)
First Publication Nation
United States
Notes
Rights Note: Diana G Zajic, ProQuest-CSA, LLC, 789 E. Eisenhower Parkway, Ann Arbor, MI, 48108-3218, United States, (800) 521-0600 xext77020, disspub@proquest.com
Statements
Application Title Statement: Combinational immunotherapy of anti-OX40 antibody and IDO inhibitor synergistically enhances anti-tumor immune T cell-mediated response
Author Statement: Zuzana Jirina Berrong Citizenship: Czech Republic Authorship: text
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.